FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Cipla Albuterol Sulfate Recall

Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations

Cipla USA, Inc. · Warren, NJ

Risk level
Class III
Reported by FDA
Aug 27, 2025
Recall ID
D-0593-2025
Check your lot numberHow we source this data

Summary

Cipla recalled Albuterol Sulfate starting Jul 24, 2025. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0593-2025 on Aug 27, 2025. Reason: Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point. Status: Ongoing.

Why it was recalled

Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.

Product description

Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, Indore, SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-142-60.

Lot numbers, UPCs & expiration codes

Lot#: 4IB0519, Exp. 04/30/2026

Where it was sold

U.S. Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0593-2025
Classification
Class III
Status
Ongoing
Recall initiated
Jul 24, 2025
FDA report date
Aug 27, 2025
Quantity
20352 packs (1x 200 MD)
Recall type
Voluntary: Firm initiated
Recalling firm
Cipla USA, Inc.

Original FDA data

Every field from FDA enforcement report D-0593-2025, exactly as published.

Show all FDA fields
City
Warren
State
NJ
Status
Ongoing
Country
United States
Event ID
97304
Address
10 Independence Blvd
Code information
Lot#: 4IB0519, Exp. 04/30/2026
Postal code
07059-2730
Report date
Aug 27, 2025
Product type
Drugs
Recall number
D-0593-2025
Classification
Class III
Recalling firm
Cipla USA, Inc.
Product quantity
20352 packs (1x 200 MD)
Reason for recall
Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, Indore, SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-142-60.
Distribution pattern
U.S. Nationwide.
Recall initiation date
Jul 24, 2025
Initial firm notification
Letter
Center classification date
Aug 20, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0593-2025, published Aug 27, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls